The first Sarepta Therapeutics trade was made in Q1 2017. Since then Ensemble Capital bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2018 and doesn't own any shares in Sarepta Therapeutics anymore.
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Oneok Inc., down $ to $5.77 to $57.95. The natural gas company is buying ...WNYT, 5 months ago
https://www.investing.com/news/pro/sarepta-therapeutics-pt-raised-to-160-at-rbc-capital-432SI-2861773Investing.com, about 1 year ago
Related Stocks: SRZN , ARYE , OLK , PTGX , LEGN , VSTM , KROS , SRPT , AFMD ,GuruFocus, almost 2 years ago
Avoro Capital Advisors LLC grew its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) by 11.6% in the second quarter, according to its most rece...Transcript Daily, almost 2 years ago